-
公开(公告)号:US20200248270A1
公开(公告)日:2020-08-06
申请号:US16709437
申请日:2019-12-10
Applicant: GUARDANT HEALTH, INC.
Inventor: AmirAli TALASAZ
IPC: C12Q1/6886 , G16B30/00 , C12Q1/6869 , C12N15/10 , C12Q1/6806 , C12Q1/6874
Abstract: The present disclosure provides a system and method for the detection of rare mutations and copy number variations in cell free polynucleotides. Generally, the systems and methods comprise sample preparation, or the extraction and isolation of cell free polynucleotide sequences from a bodily fluid; subsequent sequencing of cell free polynucleotides by techniques known in the art; and application of bioinformatics tools to detect rare mutations and copy number variations as compared to a reference. The systems and methods also may contain a database or collection of different rare mutations or copy number variation profiles of different diseases, to be used as additional references in aiding detection of rare mutations, copy number variation profiling or general genetic profiling of a disease.
-
公开(公告)号:US20190316185A1
公开(公告)日:2019-10-17
申请号:US16389680
申请日:2019-04-19
Applicant: GUARDANT HEALTH, INC.
Inventor: AmirAli TALASAZ , HELMY ELTOUKHY , Stefanie Ann Ward MORTIMER
IPC: C12Q1/6827 , G16B30/00 , C12Q1/6806
Abstract: The present disclosure provides a system and method for the detection of rare mutations and copy number variations in cell free polynucleotides. Generally, the systems and methods comprise sample preparation, or the extraction and isolation of cell free polynucleotide sequences from a bodily fluid; subsequent sequencing of cell free polynucleotides by techniques known in the art; and application of bioinformatics tools to detect rare mutations and copy number variations as compared to a reference. The systems and methods also may contain a database or collection of different rare mutations or copy number variation profiles of different diseases, to be used as additional references in aiding detection of rare mutations, copy number variation profiling or general genetic profiling of a disease.
-
公开(公告)号:US20190256927A1
公开(公告)日:2019-08-22
申请号:US16291761
申请日:2019-03-04
Applicant: GUARDANT HEALTH, INC.
Inventor: Scott KOPETZ , AmirAli TALASAZ
Abstract: Sequence variants and copy number variations in the EGFR, KRAS and MET genes are biomarkers for resistance to anti-EGFR therapies for cancer. This disclosure provides methods of detecting these biomarkers and using them in the diagnosis and treatment of cancer.
-
公开(公告)号:US20190177802A1
公开(公告)日:2019-06-13
申请号:US16277712
申请日:2019-02-15
Applicant: GUARDANT HEALTH, INC.
Inventor: AmirAli TALASAZ
IPC: C12Q1/6886 , G16B30/00 , C12Q1/6806 , C12Q1/6874 , C12N15/10 , C12Q1/6869
Abstract: The present disclosure provides a system and method for the detection of rare mutations and copy number variations in cell free polynucleotides. Generally, the systems and methods comprise sample preparation, or the extraction and isolation of cell free polynucleotide sequences from a bodily fluid; subsequent sequencing of cell free polynucleotides by techniques known in the art; and application of bioinformatics tools to detect rare mutations and copy number variations as compared to a reference. The systems and methods also may contain a database or collection of different rare mutations or copy number variation profiles of different diseases, to be used as additional references in aiding detection of rare mutations, copy number variation profiling or general genetic profiling of a disease.
-
公开(公告)号:US20180230530A1
公开(公告)日:2018-08-16
申请号:US15892178
申请日:2018-02-08
Applicant: Guardant Health, Inc.
Inventor: HELMY ELTOUKHY , AmirAli TALASAZ
IPC: C12Q1/6869 , C12Q1/6886 , G06F19/16
CPC classification number: C12Q1/6869 , C12Q1/6886 , C12Q2535/122 , C12Q2600/158 , G16B15/00
Abstract: Disclosed herein in are methods and systems for determining genetic variants (e.g., copy number variation) in a polynucleotide sample. A method for determining copy number variations includes tagging double-stranded polynucleotides with duplex tags, sequencing polynucleotides from the sample and estimating total number of polynucleotides mapping to selected genetic loci. The estimate of total number of polynucleotides can involve estimating the number of double-stranded polynucleotides in the original sample for which no sequence reads are generated. This number can be generated using the number of polynucleotides for which reads for both complementary strands are detected and reads for which only one of the two complementary strands is detected.
-
46.
公开(公告)号:US20170260590A1
公开(公告)日:2017-09-14
申请号:US15431395
申请日:2017-02-13
Applicant: Guardant Health, Inc.
Inventor: Helmy ELTOUKHY , AmirAli TALASAZ , Bahram Ghaffarzadeh KERMANI , Nnamdi IHUEGBU
CPC classification number: C12Q1/6886 , C12Q1/6827 , C12Q1/6869 , C12Q2600/118 , C12Q2600/156 , G16B30/00 , C12Q2535/113 , C12Q2545/114 , C12Q2527/113 , C12Q2535/122 , C12Q2537/149 , C12Q2537/165
Abstract: This disclosure provides, among other things, methods for generating and applying therapeutic interventions. The methods involve, for example, (a) sequencing polynucleotides from cancer cells from a subject; (b) identifying and quantifying somatic mutations in the polynucleotides; (c) developing a profile of tumor heterogeneity in the subject indicating the presence and relative quantity of a plurality of the somatic mutations in the polynucleotides, wherein different relative quantities indicates tumor heterogeneity; and (d) determining a therapeutic intervention for a cancer exhibiting the tumor heterogeneity, wherein the therapeutic intervention is effective against a cancer having the profile of tumor heterogeneity determined.
-
公开(公告)号:US20250146085A1
公开(公告)日:2025-05-08
申请号:US19018456
申请日:2025-01-13
Applicant: GUARDANT HEALTH, INC.
Inventor: Stefanie Ann Ward MORTIMER , AmirAli TALASAZ , Darya CHUDOVA , Helmy ELTOUKHY
IPC: C12Q1/6886 , C12M1/00 , C12M1/34 , C12Q1/6806 , C12Q1/6855 , C12Q1/6869 , G01N33/574 , G16B20/20 , G16B30/10 , G16H50/20 , G16H50/30
Abstract: Disclosed herein are methods, compositions, and devices for use in the early detection of cancer. The methods include preparing cell-free nucleic acid molecules from a subject for sequencing, sequencing a panel of regions in the cell-free nucleic acid molecules, and detecting one or more markers that are indicative of a cancer.
-
公开(公告)号:US20240409980A1
公开(公告)日:2024-12-12
申请号:US18770298
申请日:2024-07-11
Applicant: GUARDANT HEALTH, INC.
Inventor: Andrew KENNEDY , Stefanie Ann Ward MORTIMER , Helmy ELTOUKHY , AmirAli TALASAZ , DIANA ABDUEVA
IPC: C12Q1/6806 , C12N15/10 , C12Q1/6874 , C12Q1/6886
Abstract: The disclosure provides methods for processing nucleic acid populations containing different forms (e.g., RNA and DNA, single-stranded or double-stranded) and/or extents of modification (e.g., cytosine methylation, association with proteins). These methods accommodate multiple forms and/or modifications of nucleic acid in a sample, such that sequence information can be obtained for multiple forms. The methods also preserve the identity of multiple forms or modified states through processing and analysis, such that analysis of sequence can be combined with epigenetic analysis.
-
公开(公告)号:US20240274299A1
公开(公告)日:2024-08-15
申请号:US18642389
申请日:2024-04-22
Applicant: GUARDANT HEALTH, INC.
Inventor: Helmy ELTOUKHY , AmirAli TALASAZ
CPC classification number: G16H50/30 , C12Q1/6886 , G16B20/00 , G16B20/10 , G16B20/20 , G16B40/00 , G16H50/20 , C12Q2535/122 , C12Q2600/156
Abstract: The present disclosure provides methods for determining a probability that after any of a number of therapeutic interventions, an initial state of a subject, such as somatic cell mutational status of a subject with cancer, will develop a subsequent state. Such probabilities can be used to inform a health care provider as to particular courses of treatment to maximize probability of a desired outcome for the subject.
-
公开(公告)号:US20240167100A1
公开(公告)日:2024-05-23
申请号:US18457770
申请日:2023-08-29
Applicant: GUARDANT HEALTH, INC.
Inventor: Stefanie Ann Ward MORTIMER , AmirAli TALASAZ , Darya CHUDOVA , Helmy ELTOUKHY
IPC: C12Q1/6886 , C12M1/00 , C12M1/34 , C12Q1/6806 , C12Q1/6855 , C12Q1/6869 , G01N33/574 , G16B20/20 , G16B30/10 , G16H50/20 , G16H50/30
CPC classification number: C12Q1/6886 , C12M1/00 , C12M1/34 , C12Q1/6806 , C12Q1/6855 , C12Q1/6869 , G01N33/57407 , G16B20/20 , G16B30/10 , G16H50/20 , G16H50/30 , C12Q2600/118 , C12Q2600/154 , C12Q2600/156 , C12Q2600/158 , C12Q2600/166
Abstract: Disclosed herein are methods, compositions, and devices for use in the early detection of cancer. The methods include preparing cell-free nucleic acid molecules from a subject for sequencing, sequencing a panel of regions in the cell-free nucleic acid molecules, and detecting one or more markers that are indicative of a cancer.
-
-
-
-
-
-
-
-
-